Unveiling the Genetic Link to Chronic Bowel Disease: A New Dawn for Personalized Treatment
Unraveling the Mystery of Chronic Bowel Disease Progression
Imagine living with a chronic illness that can range from mild discomfort to a debilitating condition requiring surgery and a stoma. Now, add the constant fear of urgent toilet needs that could confine you to your home. This is the reality for approximately 60,000 Danes suffering from chronic inflammatory bowel disease (IBD).
One of the biggest challenges with IBD is that doctors cannot predict the progression of the disease for each individual. As a result, many patients are either over- or under-treated, missing the opportunity to intervene in time before the intestine is completely destroyed. But here's where it gets controversial: a new Danish study from the DNRF Center of Excellence PREDICT at Aalborg University suggests that it might be possible to predict the severity of the disease at the time of diagnosis.
The Genetic Connection
The researchers found that individuals with a higher genetic risk of developing IBD also have a greater risk of experiencing a severe course of the disease. This correlation between genetics and severity is supported by a previous study with the same research group, which showed that a specific gene, HLA-DRB1*01:03, significantly increases the risk of major surgery for people with ulcerative colitis.
A Step Towards Personalized Treatment
The study was conducted by combining national registry-based data with clinical data and material from Denmark's National Biobank for almost 8,300 Danes with chronic inflammatory bowel disease. The results were published in the renowned international journal Gastroenterology.
"Today, there is no cure for chronic inflammatory bowel disease. The disease can be controlled with medication, or in some cases by surgically removing the affected section of the intestine. However, many people experience ongoing relapses where the treatment must be changed, and the disease course is very different," says Marie Vibeke Vestergaard, the lead author on the study.
"We really lack a reliable clinical tool to choose the most appropriate strategy for the individual. The new findings represent some of the first steps towards truly personalized treatment of patients."
The Need for Biological Markers
While the new correlation between genetics and severity is a significant breakthrough, there is still a need for more knowledge about the biological markers that are crucial for preventing and organizing individual disease progression. Therefore, the new results will now be followed up by studies that test which medication and treatment strategy would be best for which subgroup.
"We know that genetics is only one of many factors that play a role in the development of the disease and its severity. Therefore, we will also continue our research. Hopefully, the results will contribute to doctors being able to offer more precise treatments in the future, so that more patients benefit from a much milder disease course," says Marie Vibeke Vestergaard.
Chronic Inflammatory Bowel Disease: The Facts
Inflammatory bowel disease (IBD) is most often divided into the diseases Crohn's disease and ulcerative colitis, which are characterized by chronic inflammation in the entire gastrointestinal area and in the colon, respectively. Every year, 2,700 Danes are diagnosed with the disease, the majority of whom are young people in their 20s to 40s. A total of approximately 60,000 people live with chronic IBD in Denmark, and the number is rising. In comparison, approximately 32,000 Danes have been diagnosed with type 1 diabetes.
Contact Information
The new study from PREDICT has just been published in the renowned international journal Gastroenterology and can be read in its entirety at Gastroenterology (https://doi.org/10.1053/j.gastro.2025.09.018).
Are you ready to dive deeper into the world of chronic bowel disease and the potential for personalized treatment? Share your thoughts and experiences in the comments below!
